Assignee
ENDOTARGET INC
US·1 granted patent·1 pending application·0 citations·filing 2022–2022
Top patents by PatentIndex Score
2 records- 0141US12139492B2Substituted pyrimidines for the targeted degradation of Bruton's tyrosine kinaseENDOTARGET INC·Filed 2022·Granted Nov 12, 2024·0 cites·15 claims
- 0239US2022348595A1Compounds and methods for the targeted degradation of estrogen receptorsENDOTARGET INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →